Free Trial
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel
NASDAQ:ICLR

Icon Q3 2026 Earnings Date & Estimates

Icon logo
$164.50 +0.42 (+0.26%)
Closing price 10/8/2026 04:00 PM Eastern
Extended Trading
$167.22 +2.72 (+1.66%)
As of 07:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Icon is expected to report Q3 2026 earnings on Tuesday, October 27, 2026, after market closes. The conference call is scheduled for October 28, 2026 at 8:00 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
8:00 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Icon in Q3 2026

Icon is expected to post earnings of $2.65 per share on revenue of $2.01 billion. Icon last reported on July 30, 2026, posting $2.56 per share and beating the $2.55 consensus estimate. Icon has beaten the consensus EPS estimate in 7 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$2.65
Expected Revenue
$2.01 billion

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$2.56 (Beat by +$0.01)
Last Quarter Revenue
$2.06 billion
EPS Beat Rate
7 of last 8 quarters

Prepare for the Q3 2026 Call

Icon Q3 2026 Earnings FAQ

Icon (NASDAQ:ICLR) is estimated to report Q3 2026 earnings on Tuesday, October 27, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Icon's Q3 2026 earnings conference call is scheduled for Wednesday, October 28, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Icon to post earnings of $2.65 per share for Q3 2026.

The consensus revenue estimate for Icon is $2.01 billion for Q3 2026.

Icon Earnings Headlines

RBC Capital Sticks to Its Buy Rating for Icon (ICLR)
 |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ICLR/pressreleases/5019746/rbc-capital-sticks-to-its-buy-rating-for-icon-iclr/
Barclays Keeps Their Hold Rating on Icon (ICLR)
 |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/ICLR/pressreleases/5046930/barclays-keeps-their-hold-rating-on-icon-iclr/
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
October 9 at 1:00 AM  |  InvestorPlace (Ad)
Icon (NASDAQ:ICLR) Shares Cross Above 200 Day Moving Average - Should You Sell?
October 9 at 2:41 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31101798
ICON Schedules Third Quarter 2026 Earnings Conference Call
October 8 at 4:01 PM  |  marketscreener.comM
Financial Comparison: Icon (NASDAQ:ICLR) versus Alpha Teknova (NASDAQ:TKNO)
October 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31078129
See More Icon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Icon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Icon and other key companies, straight to your email.

About Icon

Icon (NASDAQ:ICLR) is a global contract research and clinical development organization headquartered in Dublin, Ireland. The company provides outsourced services to pharmaceutical, biotechnology, medical device and government organizations, supporting the development and commercialization of healthcare products.

Its services span clinical trial management, clinical and regulatory consulting, data management, biostatistics, medical writing, pharmacovigilance, laboratory services, medical imaging and commercialization support. ICON works across a range of therapeutic areas and helps sponsors design, manage and analyze clinical studies in accordance with regulatory requirements.

Founded in 1990, ICON has expanded from its origins in Ireland into an international organization serving customers across North America, Europe, Asia-Pacific and other global markets. The company significantly broadened its scale and capabilities through its acquisition of PRA Health Sciences, completed in 2021. ICON is led by Chief Executive Officer Steve Cutler.

View Icon Profile
Earnings Tools